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An evaluation of the measurement properties of the Olerud
Molander Ankle Score in adults with an ankle fracture
ebecca McKeown b,∗, Helen Parsons b, David R. Ellard a, Rebecca S. Kearney a
a Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick and University Hospitals Coventry and
Warwickshire, United Kingdom
b Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, United Kingdom
bstract
bjectives  The aim of this study is to evaluate the measurement properties of the Olerud Molander Ankle Score in adults with an ankle
racture.
ethods  Patients completed outcome measure questionnaires at baseline, six, 10- and 16-weeks postinjury as part of an ongoing clinical trial
n ankle fracture rehabilitation. The internal consistency, convergent validity, structural validity and interpretability of the Olerud Molander
nkle Score was assessed. This was achieved through using the respective analysis methods of Cronbach’s alpha, correlation coefficients,
rincipal component analysis, evaluation of floor and ceiling scores and estimation of the minimally important change using anchor-based
ethods.
esults  The Olerud Molander Ankle Score showed adequate convergent validity against hypotheses set in relation to scores of comparator
nstruments. Principal component analysis demonstrated that the measure has two subscales: ankle function and ankle symptoms. The internal
onsistency of the measure and the ankle function subscale was sufficient, but inconclusive for the ankle symptoms subscale. There were no
oor and ceiling effects present within the scores and the estimated minimally important change was 9.7 points.
onclusion  The Olerud Molander Ankle Score demonstrates sufficient measurement properties and is likely to be primarily measuring the
onstruct of patient reported function following ankle fracture. Further research should evaluate the relevance of other domains to individuals
ecovering from and ankle fracture, such as social participation and psychological wellbeing. The development of a core outcome set would
e advantageous to standardise outcome measurement collection in this area.
 2021 The Author(s). Published by Elsevier Ltd on behalf of Chartered Society of Physiotherapy. This is an open access article under the
C BY license (http://creativecommons.org/licenses/by/4.0/).
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•Contribution  of  the  paper
This study evaluates the measurement properties of the
lerud Molander Ankle Score in adults with an ankle frac-
ure within the context of a clinical trial for rehabilitation
trategies in this patient population The score demonstrated sufficient construct validity, inter-
nal consistency, no floor or ceiling effects and the
minimally important change was estimated at 9.7 points.
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icense (http://creativecommons.org/licenses/by/4.0/). Factor analysis showed two subscales present; ankle func-
tion and ankle symptoms, with the latter subscale only
containing three items. The ankle function subscale is
likely to be internally consistent, but results for this are
inconclusive for the ankle symptoms subscale as it contains
too few items.
 The score is likely measuring the construct of patient
reported ankle function following ankle fracture and
should therefore be used when this specific construct of
interest is under evaluation. Other measures which may be more holistic in capturing
the multifaceted, patient important recovery from ankle
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fracture may be required to measure outcome in studies
whereby function is not the sole construct of interest.
ntroduction
Ankle fracture is the fifth most common fracture affecting
dults and contributes to the increasing socioeconomic bur-
en of lower limb fractures in the UK [1]. The injury typically
ffects younger males and older females and the incidence is
ncreasing, likely secondary to the increasing proportion of
lder individuals in the population [2]. As recommended by
uthors of a Cochrane review into rehabilitation for adults
ith ankle fracture, more high quality randomised controlled
rials (RCTs) are required to answer important questions in
his research area [3]. However, high quality results of RCTs
re dependent on high quality methods of outcome assess-
ents for the population of interest.
Outcome measures can be categorised as clinician
eported or patient reported. Over recent decades, there has
een an increasing trend towards the use of patient reported
utcome measures (PROMs) in clinical research studies [4].
owever, the outcomes must demonstrate adequate mea-
urement properties and the use of outcome measures with
nsufficient validity and reliability in clinical trials is unethi-
al and a waste of resource [5]. The Olerud Molander Ankle
core (OMAS) was developed in 1984 and is a popular
ROM used in clinical trials for this population [6,7], how-
ver results of some systematic reviews have highlighted
oncerns regarding the lack of evidence to demonstrate suffi-
ient measurement properties of this instrument [8,9]. There
re several studies which assess the measurement properties
f OMAS in different language versions [10–13] but none
hich do so in the English language version.
The aim of this study is to assess the structural and con-
ergent validity, internal consistency and interpretability of
he OMAS in a population of adults recovering from an ankle
racture. The construct of interest is patient reported outcome
ollowing ankle fracture and the context of use is outcome
easurement in RCTs.
thical  approval
Ethical approval for this validation project was sought and
ained from the West Midlands Edgbaston NHS Research
thics Committee (Reference 17/WM/0239) on 30/04/2019.
atients  and  methods
This project uses secondary analysis of pre-existing data
ollected as part of the AIR trial; a UK based multicentre
CT across 20 NHS trusts. The AIR trial compared plaster
ast to functional brace in the management of adults with
 closed ankle fracture, managed with or without surgery
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ver with a closed ankle fracture for which the treating clin-
cian felt plaster cast was a reasonable management option.
etailed eligibility criteria can be found in the supplementary
les.
ata  collection
Data were collected at baseline, 6, 10 and 16 weeks postin-
ury [14]. Baseline data and questionnaires were collected in
racture clinic prior to randomisation. Follow up question-
aires were posted to participants and returned to the trial
ffice using freepost envelopes. In the instances where postal
uestionnaires were not returned, the trial team telephoned
he participants to obtain the data over the phone within
he relevant time frame. The questionnaires collected were
MAS [6], EuroQol EQ-5D-5L (EQ-5D) [15], the Manch-
ster Oxford Foot and Ankle Questionnaire (MOXFQ) [16],
he Disability Rating Index (DRI) [17] and a Global Impres-
ion of Change (GIC) score [4]. The MOXFQ was collected at
aseline and 16 weeks only and GIC scores were collected at
6 weeks only. This set of outcome measures were collected
o measure outcome within the trial and support a comparative
valuation of OMAS.
The OMAS is a nine item questionnaire to assess patient
eported outcome following a fracture of the ankle [6]. It con-
ains single response, multiple choice questions and scores
rom 0 to 100, with higher scores indicating better outcomes.
t contains no subscales and is reported as a single index score
ith no indicated recall period.
The MOXFQ is a 16-item questionnaire to assess recovery
n individuals with foot and ankle conditions [16]. It contains
hree subscales of walking-standing, pain and social interac-
ion. The scores are 0–100 with lower scores indicating better
utcomes.
The DRI is a 12-item questionnaire which assesses lev-
ls of disability resulting from musculoskeletal conditions of
he lower limb [17]. It comprises Likert scale questions for
ndividuals to rate how easy or difficult functional tasks of
aily living are. Scores are 0–100 with lower scores indicating
igher levels of disability.
The EQ-5D is a preference-based measure of health-
elated quality of life which supports cost utility analysis. It
ontains domains of pain, usual activities, anxiety and depres-
ion, self-care, mobility all which contribute to the calculation
f a index score. The final question is an overall assessment of
uality-of-life (visual analogue scale) on the day of response,
anging from 0 to 100, with 100 being perfect health. The
K tariff crosswalk value set was used to calculate the index
core, ranging from −0.594 to 1 [15]. Individual item scores
ere used when using the domains within the EQ-5D-5L for
onvergent validity assessments.
The GIC score is a seven-point Likert scale relating tohe degree to which an individual feels they have improved
n a specified time frame, ranging from very much worse
o very much improved [4] and is shown in Table 2. This
uestion was included in the 16-week questionnaires, asking
















































Hypotheses set a priori for assessment of convergent validity.
Hypothesis Expected
correlation
Scores of OMAS will be highly negatively associated
with scores of MOXFQ and the domains of MOXFQ
of walking-standing, pain and social interaction (×4
hypotheses)
r ≤ −0.7
Scores of OMAS will be moderately negatively
associated with scores of DRI (×1 hypothesis)
r ≤ −0.5
Scores of OMAS will be moderately positively
associated with EQ-5D overall scores and EQ-5D
visual analogue scale domain (×2 hypotheses)
r ≥ 0.5
Scores of OMAS will be moderately negatively
associated with EQ-5D domains of mobility, pain &
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ndividuals to specify how much their ankle had improved
ince the previous questionnaire (10 weeks).
ample  size
The sample size for exploratory factor analysis should be
0 times the number of items in the questionnaire or greater
han 100 [5]. There are nine items in the OMAS, therefore
ata for a minimum of 100 patients are required to com-
lete exploratory factor analysis. To ensure the effects of
epeated measures were avoided for both convergent validity
nd factor analysis, each participant was only entered into
hese analyses once. A single time point was selected for
ach participant using a random number generator and the
uestionnaire for the random time point was included in the
nalysis. If a questionnaire did not exist for the randomly
llocated time point, then this participant was not entered
nto the analysis.
ata  management
Data were inputted into a secure online database acces-
ible only to authorised trial personnel. Quality assurance
rocesses were followed to ensure minimisation of error
uring data entry. All data were retrieved from the online
atabase and pseudonymised by allocating a trial ID number
y the trial statistician (HP). Dates of birth were converted
o age at randomisation and no information on randomising
ite was retrieved to protect participant confidentiality. No
nformation on allocated interventions was retrieved. Data
ere stored on secure university servers using password pro-
ected files only available to authorised trial personnel. In the
nstances where an item of data was missing from a ques-
ionnaire, we used complete case analysis, thus excluding
uestionnaires which contained one or more items of missing
ata. Mean imputation would have been the preferred method
f dealing with missing data, however individual items within
MAS are not worth an equal number of points, therefore
ean imputation is not possible with this PROM. The Data
rotection Act (2018) was adhered to in relation to the pro-
essing of all data. All data analysis was completed using
BM SPSS Statistics (Version 24).
ata  analysis
Descriptive statistics will be used to present the partici-
ant demographics and injury information of the individuals
ncluded in this study. Data presented will be age, sex, side of
njury, mechanism of injury, fracture classification and frac-
ure management. The fracture classification used to present
njury type will be the Weber classification which is widely
sed clinically [18].Convergent validity refers to how the scores of a PROM
erform in relation to scores of another PROM [19]. Con-
ergent validity was assessed using hypotheses testing for






ey: r = Pearson’s correlation.
arator instruments. Scores of OMAS will be correlated with
cores of the comparator instruments and their subscales col-
ected in the trial. As the data were normally distributed,
earson’s correlation coefficient was used to correlate the
cores. There are 12 hypotheses set a  priori  for this analy-
is, outlined in Table 1. A total of 75% hypotheses should be
et to achieve sufficient convergent validity of OMAS [20],
herefore in this case, nine of these hypotheses should be met
or OMAS to demonstrate sufficient convergent validity.
Structural validity refers to whether the PROM is an ade-
uate reflection of the dimensionality of the construct it
ntends to measure with regard to underlying subscales and
omponents of the score [19]. To our knowledge, there is
o evidence regarding the internal structure or underlying
ubscales of the OMAS [6]. We explored the dimensional-
ty using principal component analysis (PCA). Orthogonal
varimax) rotation was used and components which had
igenvalues greater than 1 were extracted. Item loadings of a
agnitude of 0.45 and above were considered sufficient for
n item to be included within a component.
Internal consistency is the degree to which items con-
ained within a PROM are interrelated with one another [19].
he internal consistency of the measure was assessed using
ronbach’s alpha. This was calculated for the total score
nd also each subscale found within the score following
ndings of PCA described above, as recommended by the
OSMIN group [21]. Acceptable scores were α = 0.70–0.95
nclusive. Cronbach’s alpha if item deleted was also calcu-
ated, whereby the result of the analysis is presented in the
ases of each item being deleted. This can indicate where
tems might be redundant and therefore not contributing to
he overall score. Item redundancy was defined as Cron-
ach’s alpha remaining constant or increasing when an item
s removed from the analysis.
Interpretability is the clinical or qualitative meaning that
ne can derive from scores, or changes in scores, of a PROM
19]. Interpretability was assessed by examining floor and
eiling (edge) effects within the score and the minimally
mportant change (MIC) of the score. Edge effects are impor-











































Fig. 1. Component plot in the rotated space.
Key: swelling EFA – swelling item, pain EFA – pain item, stiffness EFA
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ant because their presence can limit the scores ability to
etect changes in individuals who are either at the highest
r lowest points on the scale. An edge effect was defined
s present if 15% or more of the scores were at the lowest
0) and highest (100) level and this was calculated overall
nd by time point. This threshold has been recommended by
he COSMIN research group [22] and used in other stud-
es of a similar nature [23,24]. An assessment of the MIC
f OMAS was made using an anchor-based method. This
as assessed by calculating the mean change in OMAS of
espondents who reported to be “minimally improved” on the
IC score response between the 10 and 16-week follow up
uestionnaires.
esults
articipant  demographics  and  injury  information
Data for 620 participants were obtained from the trial
atabase on 26th July 2019. The mean age was 46 years
standard deviation of 16.7) with a minimum of 18 years and
aximum of 94 years. Table 2 shows the injury and demo-
raphic information of the sample. Follow up rates for the
rial by time point can be found in supplementary file C.
onvergent  validity
Table 3 shows correlations of scores of OMAS with
cores of the comparator instruments and domains of instru-
ents. The lower sample sizes for the MOXFQ outcomes are
ecause this outcome was only collected at baseline at 16
eeks.
tructural  validity
The PCA was completed using a sample of 438 study
articipants, comprised of 132 baseline scores, 110 six-week
cores, 100 10-week scores and 96 16-week scores. The mean
MAS score was 43 with a standard deviation of 26.36. Fig.
 (in supplementary files) shows the scree plot with a refer-
nce line at eigenvalue = 1. Two components can be seen to
ave eigenvalues greater than 1, hence two components were
xtracted. Fig. 1 shows the component plot in the rotated
pace for these two components. Table 4 shows results for
he extracted components.
Component 1 comprised six items; squatting, jumping,
limbing stairs, running, work/activities of daily life and sup-
orts. This subscale accounted for 45% of the variance within
cores. Due to the type of items contained within it, this
as identified as the ankle function subscale. Component comprised three items: pain, stiffness and swelling. This
ccounted for 12% of the total variance within scores and




limbing EFA – climbing stairs item, supports EFA – supports item, squat-
ing EFA – squatting item, running EFA – running item, jumpting EFA –
umping item.
nternal  consistency
Results of Cronbach’s alpha for OMAS was α  = 0.76.
able 4 shows results of Cronbach’s alpha if item deleted.
ossible item redundancy is shown as the scale internal con-
istency increases when the pain item is deleted. Results of
ronbach’s alpha for the ankle function subscale was α = 0.76
nd α  = 0.46 for the ankle symptoms subscale, however, this
as completed on a subscale containing only 3-items, so
hould be interpreted with caution.
loor  and  ceiling  effects
Table 5 shows the frequency and percentage of highest
nd lowest possible scores at each time point and overall. At
aseline, 11% of responses received were at the lowest level
nd at 16 weeks 8% of responses were at the highest level.
verall, this was 4% at the lowest score and 2% at the highest
core overall.
inimally  important  change
The mean change in OMAS scores for each GIC group
re shown in Table 6. The mean change in OMAS scores in
he minimally improved group, and therefore the MIC in this
ontext, is 9.7 points.
iscussionThe aim of this research was to explore the measurement
roperties of OMAS in a sample of individuals with ankle
racture, in the context of a multicentre RCT. Results of RCTs
an be combined to perform systematic reviews, the strongest
R. McKeown et al. / Physiotherapy 112 (2021) 1–8 5
Table 2
Injury and demographic information of sample studied.









Low energy fall 381 62
High energy fall 93 15
Other 52 8
Contact sport injury 46 7
Road traffic accident 24 4






Weber A 38 6
Weber B 409 66
Weber C 104 17
N/A (not classifiable; no lateral malleolus fracture) 25 4
Missing 44 7
Key: N/A = not applicable.
Table 3
Results of correlations for the assessment of convergent validity using hypotheses testing.
Comparator instrument/domain Sample size (n=) Pearson’s correlation with OMAS scores (r=) Significance (2 tailed)
DRI 411 −0.77 <0.01
MOXFQ 223 −0.86 <0.01
MOXFQ-pain domain 225 −0.73 <0.01
MOXFQ-walking standing domain 223 −0.85 <0.01
MOXFQ-social interaction domain 224 −0.75 <0.01
EQ-5D 442 0.73 <0.01
EQ-5D-mobility domain 442 −0.78 <0.01
EQ-5D-pain & discomfort domain 442 −0.64 <0.01
EQ-5D-self-care domain 442 −0.59 <0.01
EQ-5D-anxiety & depression domain 442 −0.34 <0.01
EQ-5D-usual activities domain 442 −0.75 <0.01
EQ-5D-visual analogue scale 441 0.56 <0.01
Table 4
Results of the principal component analysis of OMAS.
Item on questionnaire
(total points available)
Component 1 loadings of
>0.45: ankle function
subscale








Cronbach’s α if item
deleted (whole scale
α = 0.76)
Pain (25) 0.72 0.56 0.47 0.77
Stiffness (10) 0.58 0.39 0.33 0.75
Swelling (10) 0.78 0.62 0.42 0.74
Climbing stairs (10) 0.67 0.56 0.62 0.72
Running (5) 0.77 0.61 0.58 0.75
Jumping (5) 0.83 0.69 0.60 0.74
Squatting (5) 0.77 0.63 0.65 0.73








ork, activities of daily
life (20)
0.63 
evel of evidence, to enable high-quality, evidence-based
ehabilitation protocols to be developed. Results presented
ere demonstrate there are two subscales within the score:
nkle function and ankle symptoms. The Cronbach’s alpha






onsistent overall, along with the ankle function subscale.
owever, the result for Cronbach’s alpha of the ankle symp-
oms subscale is inconclusive, as it contains only three items
nd alpha is dependent upon the number of items within
 score [25]. Furthermore, the pain item contained within
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Table 5
Results of the assessment of floor and ceiling effects of OMAS.
Time point Total responses at time point (n) Frequency and percent of 0 scores n (%) Frequency and percent of 100 scores n (%)
Baseline 545 57 (11) 1 (0)
6 weeks 423 5 (1) 2 (1)
10 weeks 389 0 (0) 7 (2)
16 weeks 410 0 (0) 32 (8)
Total 1767 62 (4) 
Table 6
Mean change in OMAS scores for each GIC response group.
GIC response at 16 weeks Frequency
(n=)
Mean change in OMAS
(standard deviation where
applicable)
Very much improved 62 20.7 (14.8)
Much improved 156 15.6 (16.9)
Improved minimally 83 9.7 (14.7)
No change 21 6.4 (12.3)
Minimally worse 12 0.4 (14.4)








































































ery much worse 1 −25
he ankle symptom subscale shows a degree of item redun-
ancy. Results of the component analysis and the possible
tem redundancy of the pain item indicates that OMAS may
redominantly be measuring the construct of patient reported
unction following ankle fracture.
Scores of OMAS demonstrate adequate convergent valid-
ty in relation to scores of comparator PROMs. The only
ssociation which did not meet the a priori  hypothesis was
or EQ-5D anxiety and depression domain, which is inter-
sting because it might be expected that scores of OMAS
ay be associated with this domain. For example, if a per-
on has poor ankle function, this could cause reduction in
ctivity and social participation which could result in symp-
oms of anxiety and depression. Indeed, research shows that
ymptoms of anxiety and depression can affect individuals
ho have sustained an ankle fracture [26,27]. However, these
esults show a low association between these two scores, indi-
ating that OMAS is not capturing this domain which can
ffect this population. It is likely that OMAS does not cap-
ure the holistic concept of recovery from ankle fracture for
his reason.
We found no evidence of edge effects in the scores of the
ample included here. The MIC is consistent with those used
n RCTs in this research area [14,28,29] and will be helpful in
nabling accurate sample size calculations to be made in tri-
ls with this patient population. Other authors have assessed
he measurement properties of OMAS in different languages.
ne study translated OMAS into Turkish and evaluated the
easurement properties, finding that OMAS showed strong
orrelations with the comparator scores used and adequate
nternal consistency [10].
Another author group which also assessed a Turkish ver-




nd positive associations with scores of the Foot and Ankle
bility Measure and SF-12 [13]. However, they also found
 higher ceiling effect than results shown here, possibly
ecause of the longer follow up period studied (4.3 years).
his shows that, whilst ceiling effects are likely not an issue
p to 16 weeks postinjury, they may become an issue at
ater follow up stages. Another study assessed the MIC of
he Swedish version of OMAS, findings results of 12 points,
hich is similar to those found here [11], along with accept-
ble internal consistency.
The strengths of this study include the large sample size
hich met the criteria outlined for the principal component
nalysis. Furthermore, the sample was inclusive of both oper-
tively and non-operatively managed patients, which helps
nsure results are generalisable. Furthermore, this is over-
ue validation evidence for a very commonly used PROM,
ith comparatively little evidence for its functioning in the
atient population it is intended for, particularly in the English
anguage version of the instrument.
The main limitation of this study is that it was embedded in
n existing RCT, meaning we were restricted to the sample of
articipants within the trial, who may not be representative of
he entire population. To be eligible for the trial, individuals
ad to be suitable for plaster cast treatment. This means, for
xample, the majority of minor, avulsion type fractures will
ave been excluded from the sample because they are not
uitable for a plaster cast. Therefore, we cannot be sure that
hese results would apply to individuals with this type of
nkle fracture. Another limitation is that of missing data and
issing questionnaires; we cannot be sure that data is missing
ompletely at random, which will have introduced bias.
We were also limited to the specific data which was col-
ected in the clinical trial. For example, the assessment of
nterpretability was based upon the 10–16-week time frame,
hich is the period for which this question was asked during
he trial. This meant we were limited to assessing the inter-
retability of the score during this particular time frame and
ere unable to assess this at earlier to later stages in recovery.
urthermore, we were unable to add in additional question-
aires to assess test-retest reliability and interpretability at
ifferent time-points in an individual’s recovery, because the
articipants were already completing a significant number of
uestionnaires as part of the trial. A further limitation is the
ack of evidence for the comparator outcome measures in the
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Future research in this area should focus on ascertaining
he measurement properties of OMAS for individuals with
ractures which may not have been included in this sample,
uch as simple avulsion fractures, which would not be eligible
or this study. The measurement properties of the score at later
ime points would also be useful, to ensure that the measure is
as sufficient measurement properties for studies which use
 longer follow up period.
Researchers designing studies to evaluate interventions
nd rehabilitation protocols for individuals with an ankle frac-
ure should be mindful that the OMAS is likely a measure
f patient reported ankle function and symptoms and prob-
bly does not capture a complete biopsychosocial construct
f patient outcome following this injury. The development
f a core outcome set for this population would be advanta-
eous and findings presented here can aid with the decision on
hether OMAS should be included in this [30]. A core out-
ome set would ensure that high quality meta-analyses can
e performed on RCT results to facilitate the development
f effective and evidence-based rehabilitation protocols for
ndividuals with an ankle fracture.
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ained from the West Midlands Edgbaston NHS Research
thics Committee (Reference 17/WM/0239) on 30/04/2019.
unding  statement
The lead researcher is funded by a National Institute for
ealth Research (NIHR) Career Development Fellowship
Reference CDF-2016-09-009) for this research project.
This publication presents independent research funded by
he NIHR. The views expressed are those of the author(s) and
ot necessarily those of the NHS, the NIHR or the Department
f Health and Social Care.
onflicts  of  interest
RM, HP and DRE confirm they have no conflicts of inter-
st. RSK is a member of the UK NIHR HTA CET board,
IHR ICA Doctoral panel and previous member of the NIHR
fPB board. RSK has been awarded current and previous
IHR research grants.
cknowledgementsWe would like to thank the participants of the trial for
aking part in this study. We would also like to thank the AIR
rial management group for their help with this work.
[
rapy 112 (2021) 1–8 7
ppendix  A.  Supplementary  data
Supplementary material related to this article can
e found, in the online version, at https://doi.org/10.
016/j.physio.2021.03.015.
eferences
[1] Court-Brown C, McQueen MM, Tornetta P, Einhorn TA. Epidemiology.
In: Court-Brown C, McQueen MM, Tornetta P, Einhorn TA, editors.
Trauma. Philadelphia: Wolters Kluwer Health; 2005. p. 6.
[2] Court-Brown CM, Duckworth AD, Clement ND, McQueen MM. Frac-
tures in older adults. A view of the future? Injury 2018;49(12):2161–6.
[3] Lin CC, Donkers NA, Refshauge KM, Beckenkamp PR, Khera K,
Moseley AM. Rehabilitation for ankle fractures in adults. Cochr Datab
Syst Rev 2012;(11). N.PAG-N.PAG.
[4] Fitzpatrick R, Davey C, Buxton M, Jones D. Evaluating patient-based
outcome measures for use in clinical trials. Health Technol Assess
1998;2(14).
[5] Prinsen CAC, Mokkink LB, Bouter LM, Alonso J, Patrick DL, de
Vet HCW, et al. COSMIN guideline for systematic reviews of patient-
reported outcome measures. Qual Life Res 2018;27:1147–57.
[6] Olerud C, Molander H. A scoring scale for symptom evaluation after
ankle fracture. Arch Orthopaed Traum Surg 1984;103.
[7] McKeown R, Rabiu A-R, Ellard DR, Kearney RS. Primary outcome
measures used in interventional trials for ankle fractures: a systematic
review. BMC Musculosk Disord 2019;20(1):388.
[8] McKeown R, Ellard DR, Rabiu A-R, Karasouli E, Kearney RS. A
systematic review of the measurement properties of patient reported
outcome measures used for adults with an ankle fracture. J Pat-Rep
Outcomes 2019;3(1):70.
[9] Ng R, Broughton N, Williams C. Measuring recovery after ankle frac-
tures: a systematic review of the psychometric properties of scoring
systems. J Foot Ankle Surg 2018;57(1):149–54.
10] Buker N, Savkin R, Gokalp O, Ok N. Validity and reliability of Turk-
ish version of Olerud-Molander ankle score in patients with malleolar
fracture. J Foot Ankle Surg 2017;56(6):1209–12.
11] Nilsson GM, Eneroth M, Ekdahl CS. The Swedish version of OMAS is
a reliable and valid outcome measure for patients with ankle fractures.
BMC Musculosk Disord 2013;14:109, no pagination.
12] Garratt AM, Naumann MG, Sigurdsen U, Utvåg SE, Stavem K.
Evaluation of three patient reported outcome measures following
operative fixation of closed ankle fractures. BMC Musculosk Disord
2018;19(1):134.
13] Turhan E, Demirel M, Daylak A, Huri G, Doral MN, Celik D. Trans-
lation, cross-cultural adaptation, reliability and validity of the Turkish
version of the Olerud-Molander Ankle Score (OMAS). Acta Orthop
Traumatol Turc 2017;51(1):60–4.
14] Kearney RS, McKeown R, Stevens S, Parsons N, Parsons H, Wells
P, et al. Cast versus functional brace in the rehabilitation of patients
treated for an ankle fracture: protocol for the UK study of ankle
injury rehabilitation (AIR) multicentre randomised trial. BMJ Open
2018;8(12):e027242.
15] Devlin N, Shah K, Feng Y, Mulhern B, Hout BV. In: Research OoHE,
editor. Valuing health-related quality of life: an EQ-5D-5L value set for
England. London: Office for Health Economics; 2016.
16] Dawson J, Boller I, Doll H, Lavis G, Sharp R, Cooke P, et al. The
MOXFQ patient-reported questionnaire: assessment of data quality,
reliability and validity in relation to foot and ankle surgery. Foot
2011;21(2):92–102.
17] Parsons H, Bruce J, Achten J, Costa ML, Parsons NR. Measurement















 R. McKeown et al. / P
18] Lampridis V, Gougoulias N, Sakellariou A. Stability in ankle fractures.
EFORT Open Rev 2018;3(5):294–303.
19] Mokkink LB, Terwee CB, Patrick Sr LJ, Alonso A, Stratford PW,
Knol DL, et al. The COSMIN study reached international consensus
on taxonomy, terminology, and definitions of measurement proper-
ties for health-related patient-reported outcomes. J Clin Epidemiol
2010;63(7):737–45.
20] Abma IL, Rovers M, Van der Wees P. Appraising convergent valid-
ity of patient-reported outcome measures in systematic reviews:
constructing and interpreting outcomes. BMC Res Notes 2016;
9(226).
21] Mokkink LB, de Vet HCW, Prinsen CA, Patrick DL, Alonso J, Bouter
L, et al. COSMIN Risk of Bias checklist for systematic reviews of
Patient Reported Outcome Measures. Qual Life Res 2017;27:1171–
9.
22] Terwee C, Bot S, Boer MD, Windt DVD, Knol D, Dekker J, et al.
Quality criteria were proposed for measurement properties of health
status questionnaires. J Clin Epidemiol 2007;60.
23] Lin C, Moseley A, Refshauge K, Bundy A. The lower extremity
functional scale has good clinimetric properties in people with ankle
fracture. Phys Therapy 2009;89(6):580–8.
[
Available  online  at  www.s
ScienceDrapy 112 (2021) 1–8
24] Lim CR, Harris K, Dawson J, Beard DJ, Fitzpatrick R, Price AJ. Floor
and Ceiling effects in the OHS: an analysis of the NHS PROMs data
set. BMJ Open 2015;5(7).
25] Vaske JJ, Beaman J, Sponarski CC. Rethinking internal consistency in
Cronbach’s alpha. Leisure Scinces 2017;39(2):163–73.
26] McPhail SM, Dunstan J, Canning J, Haines TP. Life impact of ankle
fractures: qualitative analysis of patient and clinician experiences. BMC
Musculosk Disord 2012;13(224).
27] McKeown R, Kearney RS, Liew ZH, Ellard DR. Patient experiences
of an ankle fracture and the most important factors in their recovery: a
qualitative interview study. BMJ Open 2020;10(2):e033539.
28] Willett K, Keene DJ, Mistry D, Nam J, Tutton E, Handley R, et al.
Close contact casting vs surgery for initial treatment of unstable
ankle fractures in older adults: a randomized clinical trial. JAMA
2016;316(14):1455–63.
29] Kortekangas T, Haapasalo H, Flinkkilä T, Ohtonen P, Nortunen S, Laine
H-J, et al. Three week versus six week immobilisation for stable Weber
B type ankle fractures: randomised, multicentre, non-inferiority clinical
trial. BMJ 2019;364:k5432.
30] Clarke M, Williamson P. Core outcome sets and trial registries. Trials
2015;16(1):216.
ciencedirect.com
irect
